Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Two Announcements from Tongjitang Chinese Medicines

publication date: May 20, 2008

Tongjitang Chinese Medicines Company reported that production at its Xiuwen facility has resumed, one week after the company announced the manufacturing plant would shut down temporarily following the central China earthquake. At the time, Tongjitang said it was not certain the water quality in the facility was assured, necessitating a shutdown until water quality was tested and found safe. Tongjitang also said it has received a tax rebate of 16 million RMB ($2.3 million) from the local taxation authority, which it will use to expand its China operations. More details...

Stock Symbol: (NYSE: TCM)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital